Table S0. Samples included in each analysis.

Table S1. Self-identified race and ethnicity in TCGA prostate cancer cohort.

Table S2. Global genetic ancestry annotation of TCGA-PRAD patients estimated by EIGENSTRAT.

Table S3. Global genetic ancestry annotation of TCGA-PRAD patients estimated by STRUCTURE.

Table S4. Global genetic ancestry annotation of TCGA-PRAD patients estimated by LAMP.

Table S5. Clinical characteristics of TCGA-PRAD patients.

Table S6. Differential contributions of mutational signatures among AA and EA patients.

Table S7. Differences in mutation frequency between AA and EA patients for 21 prostate cancer-related genes

Table S8. Differences in fusion event frequency between AA and EA patients.

Table S9. Differences in SCNA frequency between AA and EA patients.

Table S10. Genes differentially expressed between AA and EA patients identified by DESeq2 analysis adjusting for clinical factors.

Table S11. Gene sets significantly enriched in DEGs upregulated in AA tumors.

Table S12. Gene sets significantly enriched in DEGs downregulated in AA tumors.

Table S13. lncRNA genes differentially expressed between AA and EA patients identified by DESeq2 analysis adjusting for clinical factors.









Contact us | | Terms & Conditions.
Copyright © 2015 University of Pennsylvania. All Rights Reserved.